Dolby Laboratories (DLB) traded lower as the market digested its latest quarterly update and, more importantly, its forward outlook. While results showed year-over-year revenue growth to about $396 million, investors zeroed in on guidance calling for next-quarter revenue of around $310 million, which was framed as meaningfully below consensus expectations.

In the fiscal second quarter of 2026, Dolby reported revenue of roughly $395.6 million and GAAP diluted EPS of $0.99, with non-GAAP EPS of $1.37. Management maintained full-year FY2026 guidance of about $1.40 billion to $1.45 billion in revenue and non-GAAP EPS of $4.30 to $4.45, but the near-term quarterly revenue outlook became the focal point for the selloff.

For a licensing-heavy model like Dolby’s, quarterly guidance can signal changes in device volumes, content distribution trends, and the timing of royalty reporting. A softer near-term revenue view can raise concerns that licensing momentum or partner demand is slowing, even if the longer-run full-year range remains intact.

Investors will be tracking any follow-through commentary on licensing trends, the cadence of royalty reports and payments, and whether management reiterates confidence in the back-half setup implied by full-year guidance. Updates around key end markets such as mobile, consumer electronics, broadcast, and cinema will also shape whether today’s move proves transitory or the start of a deeper reset in expectations.